Abstract

Sexual dysfunction is common in depressive illness, most often occuring as loss of sexual interest, impotence, and a decline in the frequency of intercourse. Antidepressant drugs have been documented to improve sexual function in depression; however, adverse effects of sexual function also occur as a result of the drugs' interference with peripheral cholinergic and adrenergic function. MAO inhibitors may also ameliorate depression-related sexual dysfunction. These drugs also improve sperm count and sperm motility and may have a clinical use in moderate oligospermia. Stimulant drugs have been linked to a wide variety of sexual effects. Most dramatic is the increase in sexual arousal reported by many stimulant users. Increases in sexual activity and sexual perversion have both been related to stimulant use. Due to the high rate of pre-drug sexual aberration and the non-specific nature of stimulant arousal, caution should be exercised in postulating a direct effect on sexuality by stimulant drugs.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.